IndraLab

Statements



eidos
"In the HER2 positive cell line SKBR3 , silencing all three early stage antigens decreased survival ( PDHX and STK39 p < 0.0001 and OTUD6B p =0 .05 ) and both STK39 and OTUD6B increased apoptosis ( STK39 p =0 .0002 and OTUD6B p < 0.0001 ) ."